The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation

G Mowatt; G Scotland; C Boachie; M Cruickshank; J A Ford; C Fraser; L Kurban; T B Lam; A R Padhani; J Royle; T W Scheenen; E Tassie

doi:10.3310/hta17200

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation

G Mowatt, G Scotland, C Boachie, M Cruickshank, J A Ford, C Fraser, L Kurban, T B Lam, A R Padhani, J Royle, T W Scheenen, E Tassie

Research output: Contribution to journal › Article › peer-review

101 Citations (Scopus)

Abstract

In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.

Original language	English
Pages (from-to)	vii-xix, 1-281
Journal	Health Technology Assessment
Volume	17
Issue number	20
DOIs	https://doi.org/10.3310/hta17200
Publication status	Published - May 2013

Keywords

Biopsy
Cost-Benefit Analysis
Diffusion Magnetic Resonance Imaging
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Male
Prostate
Prostatic Neoplasms

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3310/hta17200

Cite this

Mowatt, G., Scotland, G., Boachie, C., Cruickshank, M., Ford, J. A., Fraser, C., Kurban, L., Lam, T. B., Padhani, A. R., Royle, J., Scheenen, T. W., & Tassie, E. (2013). The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation. Health Technology Assessment, 17(20), vii-xix, 1-281. https://doi.org/10.3310/hta17200

Mowatt, G ; Scotland, G ; Boachie, C ; Cruickshank, M ; Ford, J A ; Fraser, C ; Kurban, L ; Lam, T B ; Padhani, A R ; Royle, J ; Scheenen, T W ; Tassie, E. / The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy : A systematic review and economic evaluation. In: Health Technology Assessment. 2013 ; Vol. 17, No. 20. pp. vii-xix, 1-281.

@article{3086ddd9b910444f9c251f58122067fb,

title = "The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation",

abstract = "In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.",

keywords = "Biopsy, Cost-Benefit Analysis, Diffusion Magnetic Resonance Imaging, Humans, Magnetic Resonance Imaging, Magnetic Resonance Spectroscopy, Male, Prostate, Prostatic Neoplasms",

author = "G Mowatt and G Scotland and C Boachie and M Cruickshank and Ford, {J A} and C Fraser and L Kurban and Lam, {T B} and Padhani, {A R} and J Royle and Scheenen, {T W} and E Tassie",

year = "2013",

month = may,

doi = "10.3310/hta17200",

language = "English",

volume = "17",

pages = "vii--xix, 1--281",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "National Co-ordinating Centre for HTA",

number = "20",

}

Mowatt, G, Scotland, G, Boachie, C, Cruickshank, M, Ford, JA, Fraser, C, Kurban, L, Lam, TB, Padhani, AR, Royle, J, Scheenen, TW & Tassie, E 2013, 'The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation', Health Technology Assessment, vol. 17, no. 20, pp. vii-xix, 1-281. https://doi.org/10.3310/hta17200

The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy : A systematic review and economic evaluation. / Mowatt, G; Scotland, G; Boachie, C; Cruickshank, M; Ford, J A; Fraser, C; Kurban, L; Lam, T B; Padhani, A R; Royle, J; Scheenen, T W; Tassie, E.

In: Health Technology Assessment, Vol. 17, No. 20, 05.2013, p. vii-xix, 1-281.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy

T2 - A systematic review and economic evaluation

AU - Mowatt, G

AU - Scotland, G

AU - Boachie, C

AU - Cruickshank, M

AU - Ford, J A

AU - Fraser, C

AU - Kurban, L

AU - Lam, T B

AU - Padhani, A R

AU - Royle, J

AU - Scheenen, T W

AU - Tassie, E

PY - 2013/5

Y1 - 2013/5

N2 - In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.

AB - In the UK, prostate cancer (PC) is the most common cancer in men. A diagnosis can be confirmed only following a prostate biopsy. Many men find themselves with an elevated prostate-specific antigen (PSA) level and a negative biopsy. The best way to manage these men remains uncertain.

KW - Biopsy

KW - Cost-Benefit Analysis

KW - Diffusion Magnetic Resonance Imaging

KW - Humans

KW - Magnetic Resonance Imaging

KW - Magnetic Resonance Spectroscopy

KW - Male

KW - Prostate

KW - Prostatic Neoplasms

U2 - 10.3310/hta17200

DO - 10.3310/hta17200

M3 - Article

C2 - 23697373

VL - 17

SP - vii-xix, 1-281

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 20

ER -

Mowatt G, Scotland G, Boachie C, Cruickshank M, Ford JA, Fraser C et al. The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: A systematic review and economic evaluation. Health Technology Assessment. 2013 May;17(20):vii-xix, 1-281. https://doi.org/10.3310/hta17200